Clinical trial
ACP Max™ PRP System for Knee Osteoarthritis: A Feasibility Trial
NCT05765266 is registered in ClinicalTrials.gov with Arthrex, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ACP Max™ PRP System for Knee Osteoarthritis: A Feasibility Trial
- Lead sponsor
- Arthrex, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 13, 2024
- Completion date
- February 9, 2026
- Enrollment
- 45 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
knee osteoarthritis